PARP inhibition in BRCA2-mutated prostate cancer.
Department of Urology, Section of Molecular Urooncology, University Hospital Heidelberg, Heidelberg,  Germany.
C
C
Nientiedt
Department of Urology, Section of Molecular Urooncology, University Hospital Heidelberg, Heidelberg,  Germany.
Y
Y
Tolstov
Department of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
A-L
AL
Volckmar
Department of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
V
V
Endris
Department of Radiology, German Cancer Research Center, Heidelberg, Germany.
D
D
Bonekamp
Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
U
U
Haberkorn
Department of Urology, Section of Molecular Urooncology, University Hospital Heidelberg, Heidelberg,  Germany.
D
D
Jäger
German Cancer Research Center, Cancer Genome Research, and German Cancer Consortium, Heidelberg, Heidelberg, Germany.
H
H
Sültmann
Department of Urology, Section of Molecular Urooncology, University Hospital Heidelberg, Heidelberg,  Germany.
A
A
Stenzinger
Department of Urology, Section of Molecular Urooncology, University Hospital Heidelberg, Heidelberg,  Germany.
M
M
Hohenfellner
Department of Urology, Section of Molecular Urooncology, University Hospital Heidelberg, Heidelberg,  Germany.|National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany.
C
C
Grüllich
Department of Urology, Section of Molecular Urooncology, University Hospital Heidelberg, Heidelberg,  Germany.
S
S
Duensing
D024682:BRCA2 Protein / Q000235:genetics*; D018095:Germ-Line Mutation; D006801:Humans; D008297:Male; D008875:Middle Aged; D010793:Phthalazines / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*; D000067856:Poly(ADP-ribose) Polymerase Inhibitors / Q000627:therapeutic use*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy* / Q000235:genetics*
D024682:BRCA2 Protein; C551750:BRCA2 protein, human; D010793:Phthalazines; D010879:Piperazines; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; C531550:olaparib